-
(1R,4S,5R,8S,9R,10R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecan-10-ol
-
ChemBase ID:
72936
-
Molecular Formular:
C15H24O5
-
Molecular Mass:
284.34806
-
Monoisotopic Mass:
284.16237387
-
SMILES and InChIs
SMILES:
C1C[C@@H]2[C@]34[C@H]([C@@H]1C)CC[C@@](O[C@H]3O[C@H]([C@@H]2C)O)(C)OO4
Canonical SMILES:
O[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@@H]4[C@]2([C@H]([C@H]1C)CC[C@H]4C)OO3
InChI:
InChI=1S/C15H24O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-13,16H,4-7H2,1-3H3/t8-,9-,10+,11+,12-,13-,14-,15-/m1/s1
InChIKey:
BJDCWCLMFKKGEE-KDTBHNEXSA-N
-
Cite this record
CBID:72936 http://www.chembase.cn/molecule-72936.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(1R,4S,5R,8S,9R,10R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecan-10-ol
|
|
|
IUPAC Traditional name
|
(1R,4S,5R,8S,9R,10R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecan-10-ol
|
|
|
Synonyms
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
12.114969
|
H Acceptors
|
5
|
H Donor
|
1
|
LogD (pH = 5.5)
|
2.8382654
|
LogD (pH = 7.4)
|
2.838257
|
Log P
|
2.8382654
|
Molar Refractivity
|
69.9093 cm3
|
Polarizability
|
28.899292 Å3
|
Polar Surface Area
|
57.15 Å2
|
Rotatable Bonds
|
0
|
Lipinski's Rule of Five
|
true
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
Storage Condition
|
-20°C
|
Show
data source
|
|
Salt Data
|
Free Base
|
Show
data source
|
|
DETAILS
DETAILS
Selleck Chemicals
Selleck Chemicals -
S2290
|
Research Area: Infection Biological Activity: Dihydroartemisinin (DHA) is a semi-synthetic derivative of artemisinin and isolated from the traditional Chinese herb Artemisia annua. It is the active metabolite of all artemisinin compounds. It is recommended as the first-line anti-malarial drug with low toxicity. DHA has been shown to possess promising anticancer activities and induce cancer cell death through apoptotic pathways. [1] It is also a drug used to treat malaria. The lactone of artemisinin could selectively be reduced with mild hydride-reducing agents, such as sodium borohydride, potassium borohydride, and lithium borohydride to dihydroartemisinin (a lactol) in over 90% yield. [2] |
PATENTS
PATENTS
PubChem Patent
Google Patent